Back to the search results

Rems-Murr-Klinikum Winnenden

Rems-Murr-Klinikum Winnenden
Rems-Murr-Klinikum Winnenden

Am Jakobsweg 1
71364 Winnenden

Phone: 07195-591-0
Fax: 017195-591-952000
Mail: ed.nekinilk-rrum-smer@gnurheufstfeahcseg-tairaterkes

  • Number of beds: 667
  • Number of specialist departments: 20
  • Number of inpatient cases: 31.990
  • Number of partial inpatient cases: 4
  • Number of outpatient cases: 73.464
  • Hospital owners: Rems-Murr-Kliniken gGmbH
  • Type of provider: öffentlich
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 167
Exception? No exception
Quantity performed 4
Exception? No exception
Quantity performed 22
Exception? No exception
Quantity performed 27
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 167
Quantity forecast year: 190
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: no
Quantity performed reporting year: 4
Quantity forecast year: 4
Examination by state associations? no
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 22
Quantity forecast year: 28
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 27
Quantity forecast year: 27
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 32
Quantity forecast year: 30
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 194
Quantity forecast year: 210
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 49
Quantity forecast year: 56
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ07 Measures for quality assurance in the care of pre-term and full-term neonates – perinatal focus
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
191 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
129 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
116 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • Note on the measure: Behandlungsablauf KiJu bei Verdacht auf Kindeswohlgefährdung
  • Last review of the measure: 27.01.2021 11:46:46
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Fallbesprechungen
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
  • Aushändigung des Medikationsplans
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Gynäkol.&Geburtsh:Greifswald,Sevilla,Maryland;Onkol.,Hämatol.&Palliativmed: Dresden;Kinder-&Jugendmedizin:Tübingen;Neurologie:Magdeburg;Allgemein-&Viszeralchirg:Bochum;Kardiologie:Regensburg;Radiologie:Tübingen;Innere Medizin/Gastroenterologie:Göttingen;Thoraxchirg:Münster

Explanation

Lehrbeauftragter Herr Dr. Schliep an der VWA Stuttgart, Universität Augsburg und Universität Berlin.

Explanation

Gyn. u. Geburtshilfe;Kinder- u. Jugendmed.,Allg.- u. Viszeralchir.;Gefäßchir.;Hämatologie,Onkologie u. Palliativmed.;Anaesthesie u. Intensivmed.;Kardiologie;Radiolo.;Neurologie;Urologie(Famulatur);Pneumologie;Thoraxchir.,Gastroenterologie,Allg. Innere, Labormed.,Notaufn.,Klin. Akut- u. Notfallmed.

Explanation

Kinder-/Jugendmed.(Uni Tübingen);Gynäkol.(Uni Greifswald, Heidelb., Tüb.);Onkol./Hämatol.(Uni Düsseldorf, Dresden,Tüb.);Gastroenterol.&Allgem. Innere&Geriatrie; Kardiol.(Uni Regensb.),Unfallchirg/Orthop.;Neurol.(Uni Tüb., Magdeb.);Radiol.(Uni Tüb.);Thoraxchirg(Uni Heidelb.,Uni Münster)

Explanation

Hämatologie, Onkologie und Palliativmedizin; Allgemein-und Viszeralchirurgie (im Rahmen des Pankreas - und Darmzentrums)

Explanation

Gynäkologie; Onkologie und Hämatologie; Kardiologie; Urologie; Neurologie; Allgemein-und Viszeralchirurgie; Kinder - u. Jugendmedizin

Explanation

Gynäkologie /Prof. Strittmatter; Darmkebszentrum /PD Dr. Müller; Thoraxchirurgie /PD Dr. Marra

Explanation

Strittmatter:Atyp. juveniles Fibroadenom vs. Borderline-Phylloidestumor b. einer 17jä. Pat..Jama Oncology,doi:10.1001/2020.7442;S.Karger AG,BreastCare 2021;16:335-342, DOI:10.1159/000509568;BreastCare2021;16:461-467,DOI: 10.1159/000512201;Kramer Et al,2018Radiol. Diff.-diag. Herz&große Gefäße;Thieme

Explanation

Gynäkologie und Geburtshilfe; Hämatologie, Onkologie und Palliativmedizin; Allgemein-und Viszeralchirurgie; Unfallchirurgie/Orthopädie; Neurologie; Radiologie; Thoraxchirurgie; Gastroenterologie, Kardiologie

Training in other healing professions
Comment

Bildungszentrum für Gesundheitsberufe in Trägerschaft der RMK (65%) und des zfp (35%)

Comment

Bildungszentrum für Gesundheitsberufe

Comment

Wird in Kooperation mit der MTA-Esslingen angeboten

Comment

Wird in Kooperation mit der Diakoneo-OTA-Schule Schwäbsich Hall angeboten. Kooperation mit der Akadamie für Gesundheitsberufe des Klinikverbunds Südwest bis 31.03.2022.

Comment

Bildungszentrum für Gesundheitsberufe sowie ab 2021 Studium in Kooperation DHBW Stuttgart

Comment

Bildungszentrum für Gesundheitsberufe

Comment

Bildungszentrum für Gesundheitsberufe in Trägerschaft der RMK (65%) und des zfp (35%)

Frau Ursula Bodamer

Patientenfürsprecher

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-57100
Mail: ed.nekinilk-rrum-smer@remadoB.alusrU

Herr Paul Hug

Patientenfürsprecher

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-57100
Mail: ed.nekinilk-rrum-smer@guH.luaP

Frau Sarah Kluske

Patienten- und Beschwerdemanagement

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-57002
Mail: ed.nekinilk-rrum-smer@kitirkbol

Brigitte Strätker-Klumpp

Leitung Stabsstelle Qualitäts- und Klinisches Risikomanagement

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-52010
Mail: ed.nekinilk-rrum-smer@mq

Prof. Dr. Ralf Rauch

Ärztlicher Direktor

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-39200
Mail: ed.nekinilk-rrum-smer@nednenniw.eirtaideap

Harald Wolny

Leitung Zentralapotheke

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-52220
Mail: ed.nekinilk-rrum-smer@ekehtopalartneZ

Frau Silke Haase

Teamleitung Information

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-10240
Mail: ed.nekinilk-rrum-smer@nednenniW-noitamrofni

Matthias Haller

Pflegedienstleitung

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-51100
Mail: ed.nekinilk-rrum-smer@gnurheufstfeahcseg-tairaterkes

Claudia Bauer-Rabe

Klinikleitung Rems- Murr-Klinikum Winnenden

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-51100
Mail: ed.nekinilk-rrum-smer@gnurheufstfeahcseg-tairaterkes

Dr. med. Marc Nickel

Geschäftsführer

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-52000
Mail: ed.nekinilk-rrum-smer@ofni

André Mertel

Geschäftsführer

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-52000
Mail: ed.nekinilk-rrum-smer@gnurheufstfeahcseg.tairaterkes

Prof. Dr. Ralf Rauch

Ärztlicher Direktor; Chefarzt der Klinik für Kinder- und Jugendmedizin

Am Jakobsweg 1
71364 Winnenden

Phone: 07195 -591-39200
Mail: ed.nekinilk-rrum-smer@eirtaideap

IK: 260810738

Location number: 773028000

Old location number: 773028000